Inflexion in 2.8x pharma exit

The UK-based firm has agreed to sell Phlexglobal to Bridgepoint Development Capital for £42m

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this